Featured this week: Amani Bashir, MBBS, Dawn Quelle, PhD

• Initial experience in implementing quantitative DCE-MRI to predict breast cancer therapy response in a multi-center and multi-vendor platform setting. Moloney B, Li X, Hirano M, Saad Eddin A, Lim JY, Biswas D, Kazerouni AS, Tudorica A, Li I, Bryant ML, Wille C, Pyle C, Rahbar H, Hsieh SK, Rice-Stitt TL, Dintzis SM, Bashir A, Hobbs E, Zimmer A, Specht JM, Phadke S, Fleege N, Holmes JH, Partridge SC, Huang W. Front Oncol. 2024 Nov 29;14:1395502. doi: 10.3389/fonc.2024.1395502. eCollection 2024.
   
• GLP-1R agonist promotes proliferation of neuroendocrine neoplasm cells expressing GLP-1 receptors.
  Shilyansky JS, Chan CJ, Xiao S, Gribovskaja-Rupp I, Quelle DE, Howe JR, Dillon JS, Ear PH.
  Surgery. 2024 Dec 10:108943. doi: 10.1016/j.surg.2024.09.052. Online ahead of print.